Skip to main content
YUHAN CORPORATION logo

YUHAN CORPORATION — Investor Relations & Filings

Ticker · 000100 ISIN · KR7000100008 KO Manufacturing
Open in API
Filings indexed 636 across all filing types
Latest filing 2025-07-30 Earnings Release
Country KR South Korea
Listing KO 000100

About YUHAN CORPORATION

http://eng.yuhan.co.kr

Yuhan Corporation, established in 1926, is an integrated healthcare company engaged in the discovery, development, manufacturing, and marketing of pharmaceutical products. Its diverse portfolio encompasses prescription drugs, over-the-counter (OTC) medications, Active Pharmaceutical Ingredients (APIs), and intermediates for various therapeutic areas, including antibiotics and antivirals. The company also produces veterinary drugs and household goods. In addition to its own product lines, Yuhan operates as a Contract Development and Manufacturing Organization (CDMO), offering comprehensive services to the pharmaceutical sector. Through its affiliates, the company is also involved in specialized areas such as nutrient infusion solutions.

Recent filings

Filing Released Lang Actions
영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) from Yuhan Corporation. It provides key financial highlights (revenue, operating profit, net income) for the second quarter of 2025. It is a concise summary of financial performance rather than a full quarterly report or a mere announcement of a report's publication. Therefore, it fits the definition of an Earnings Release (ER). H1 2025
2025-07-30 Korean
주요사항보고서(자기주식취득신탁계약해지결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean Financial Supervisory Service/Korea Exchange regarding the termination of a trust agreement for the acquisition of treasury shares (자기주식취득 신탁계약 해지 결정). This document details the company's decision to terminate a share buyback trust and the subsequent handling of those shares. According to the provided filing definitions, reports concerning a company buying back or selling its own shares are classified as 'Transaction in Own Shares' (POS).
2025-07-30 Korean
기업설명회(IR)개최(안내공시)
Report Publication Announcement Classification · 100% confidence The document is a short announcement (672 characters) regarding the scheduling of an upcoming Investor Relations (IR) meeting. It provides the date, time, and purpose of the meeting but does not contain the actual presentation or financial results themselves. According to the 'Menu vs Meal' rule, an announcement of a report or event is classified as a Report Publication Announcement (RPA) or Regulatory Filing (RNS). Since this is a formal regulatory notice of an upcoming corporate event, it fits best as a Report Publication Announcement (RPA).
2025-07-29 Korean
주요사항보고서(자기주식취득결정)
Transaction in Own Shares Classification · 100% confidence The document is a formal 'Major Matters Report' (주요사항보고서) filed with the Korean Financial Supervisory Service/Korea Exchange. It specifically details a 'Decision to Acquire Treasury Shares' (자기주식 취득 결정), including the number of shares, acquisition method, and purpose. This falls directly under the definition of a company buying back its own shares, which corresponds to the 'Transaction in Own Shares' (POS) category.
2025-07-01 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a standard regulatory requirement for directors and major shareholders to disclose their personal share transactions (insider trading). Based on the provided definitions, this falls under 'Director's Dealing' (DIRS).
2025-06-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details a transaction (purchase of shares) by a company executive (Jo Wook-je, CEO of Yuhan Corporation). This type of filing is a standard regulatory requirement for insider trading/shareholding disclosures, which corresponds to the 'Director's Dealing' category.
2025-06-26 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.